TARS vs CDTX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

TARS

60.2
AI Score
VS
TARS Wins

CDTX

49.9
AI Score

Investment Advisor Scores

TARS

60score
Recommendation
STRONG BUY

CDTX

50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric TARS CDTX Winner
Forward P/E 56.8182 5.7504 CDTX
PEG Ratio 0 0 Tie
Revenue Growth 63.9% -100.0% TARS
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 60.2/100 49.9/100 TARS
Profit Margin -102.9% 0.0% CDTX
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY HOLD TARS

Relative Price Performance (Last 90 Days)

TARS 1M: +8.4% · 3M: +11.4% CDTX 1M: +0.3% · 3M: +117.1%

Current Technical Phase

TARS

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (0.6% over 20 days), RSI 59

RSI (14): 59.4 · Price: $76.76

CDTX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (34.6% over 20 days), RSI 85

RSI (14): 84.6 · Price: $221.38

Fundamentals Snapshot

Metric TARS CDTX
Market Cap — —
Forward P/E 357.0 -35.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.6% -1.0%
Gross Margin 0.8% —
Operating Margin -0.2% 0.0%
EPS -15.86 -11.22
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, TARS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.